Amydis Diagnostics' Grant - IV Round

Amydis Diagnostics raised a round of funding on July 10, 2018. Investors include The Michael J. Fox Foundation.

Amydis is a privately-held pharmaceutical company focused on developing chemistry to detect diseases that involve the presence of amyloid proteins. The company's mission is to develop a universal, non…

Articles about Amydis Diagnostics' Grant - IV Round: